EUVIMEDEUVIMED entdecken
Crossref

Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening

Mahesh D Vaghasiya iD, Arindam Sain iD, Jigarkumar V Mendapara iD, Dipshikha Khamrai, Debdut Naskar iD, Premlata Kumari iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202401550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Mahesh D Vaghasiya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, S.V. National Institute of Technology, Surat, Gujarat, 395007, India. Hauptthemen laut MEDLINE: Thiazepines, Antineoplastic Agents, Drug Design, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Sardar Vallabhbhai National Institute of Technology in Surat, India, Banaras Hindu University, Maulana Abul Kalam Azad University of Technology in West Bengal, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel thiazepine‐based hybrids (9 a – d) were designed and synthesized to create lead molecules with exceptional anti‐colon cancer efficacy. Analytical methods, including IR, NMR, and HR‐MS, characterized the synthesized compounds. The in vitro colorectal study was carried out to compare the biological activity of newly developed compounds with the computational data. The tested compounds induced cytotoxicity in HT‐29 cells for both 24 h and 48 h in a dose‐dependent manner. However, compound 9 a induced cytotoxicity at much higher concentrations compared to the rest of the compounds. 9 b and 9 c caused 50 % cell death (compared to the untreated cells) at a dose of ~50 μM and 40 μM in case of 24‐hour exposure, respectively. On the contrary, for 48 h exposure, both 9 b and 9 c induced 50 % cell death concerning untreated cells at a dose of around ~20 μM, whereas 9 d exhibited 50 % cell death at 5 μM in the case of 48 h exposure. In silico ADMET was also carried out to understand the pharmacokinetics and safety profiles of the drug candidates. We found some of the critical targets of these compounds, which eventually will be integral to exploring the mechanistic actions of these compounds in colon cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiazepinesAntineoplastic AgentsDrug DesignDrug Screening Assays, AntitumorColonic NeoplasmsHumansStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugCell ProliferationHT29 CellsCell Survival

Stichwörter der Autor:innen

Colorectal cancerComputational analysisEGFRHT-29 cellsThiazepine hybrids

Substanzen

ThiazepinesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, S.V. National Institute of Technology, Surat, Gujarat, 395007, India.
  • Department of Biotechnology, Maulana Abul Kalam Azad University of Technology, Haringhata, Nadia, West Bengal, 741249, India.

ORCID-Profile: Mahesh D Vaghasiya, Arindam Sain, Jigarkumar V Mendapara, Debdut Naskar, Premlata Kumari

Förderung

  • Sardar Vallabhbhai National Institute of Technology in Surat, India
  • Banaras Hindu University
  • Maulana Abul Kalam Azad University of Technology in West Bengal, India

Zitieren

APA

Vaghasiya, M. D., Sain, A., Mendapara, J. V., Khamrai, D., Naskar, D., & Kumari, P. (2025). Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401550

Vancouver

Vaghasiya MD, Sain A, Mendapara JV, Khamrai D, Naskar D, Kumari P. Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401550

BibTeX
@article{Vaghasiya2025,
  author = {Vaghasiya, Mahesh D and Sain, Arindam and Mendapara, Jigarkumar V and Khamrai, Dipshikha and Naskar, Debdut and Kumari, Premlata},
  title = {Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202401550}
}
Kostenlos starten →